continued from page 15


Group-Specific Use Recommendations


When Presenting to Patients      


   through their union or human resources department.


  promoting chiropractic-friendly policy and legislation.


When Presenting to Legislators  


  management.


  managed by chiropractic care.


  with respect to opioid use over the years, and that chiropractic-friendly policies and legislation are required.


 


When Presenting to Payers  


  effectiveness and insurance cost savings with chiropractic care inclusion (JMPT 2005), ACF 2017 Low Back Pain Practice Guideline, etc.*


When Sharing with GP & Specialty Medical Providers **


  options for pain management, especially back and neck pain 


  access to reasonable pain management care options.


  CMT pain management, such as rehabilitation/exercise, patient  cognitive-behavioral therapy integration, etc.


 


  (using the Optum study, etc.*).


   


When Sharing with Non-medical Providers


  options for pain management, especially back and neck pain.


  access to reasonable pain management care options.


  


  NMS conservative care specialist.


* Contact the WSCA if any of these studies or information is needed.


** Understand that the WSCA Opioid brochure contrasts the differences between medical and chiropractic practice. It may produce a defensive reaction in some medical circles. Keep your focus patient-centered. Handle this strategically by personalizing your message, and working to improve your own interprofessional relationships. Discuss the brochure as a third-party publication (not your own) and center the discussion on patient care. It is best to make sure you have a good understanding about the complexities of pain and chronic pain, and have a range of strategies in place in your practice to address various pain management issues (rehabilitation pathways, MD care coordination, patient engagement, etc.).


16 www.chirohealth.org


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36